ArticlePharmaceuticals (Basel, Switzerland)2022

Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors.

Sofia Koustoulidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.